Concepedia

Antonio Cebriá

AC

12

Publications

504

Citations

11

H-Index

1994

Active since

Affiliations

Spanish National Cancer Research Centre(Current)

Antonio Cebriá is an author at Spanish National Cancer Research Centre specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

1994–2021

12

Publications

12

Gp96 is a receptor for a novel Listeria monocytogenes virulence factor, Vip, a surface protein

Didier Cabanes, Sandra Sousa, Antonio Cebriá et al. · The EMBO Journal · 2005 · 181 citations · Full text

, , +11

Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases

Wolfgang Link, Julen Oyarzábal, Beatriz G. Serelde et al. · Journal of Biological Chemistry · 2009 · 79 citations · Full text

Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors

Joaquı́n Pastor, Julen Oyarzábal, Gustavo Saluste et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 44 citations · Full text

, , +9

A novel phosphatidylinositol 3-kinase (PI3K) inhibitor directs a potent FOXO-dependent, p53-independent cell cycle arrest phenotype characterized by the differential induction of a subset of FOXO-regulated genes

Richard Hill, Ravi Kiran Reddy Kalathur, Sergio Callejas et al. · Breast Cancer Research · 2014 · 41 citations · Full text

Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors

Sonia Martı́nez, Sonsoles Rodríguez-Arístegui, Cristina Gómez de la Oliva et al. · European Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

, , +6

Rows per page

1–5 of 12